AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Volumn 23, Issue , 2017, Pages 1-87

  Jellinger, Paul S ^a   Handelsman, Yehuda ^a   Rosenblit, Paul D ^a   Bloomgarden, Zachary T ^a   Fonseca, Vivian A ^a   Garber, Alan J ^a   Grunberger, George ^a   Guerin, Chris K ^a   Bell, David S H ^a   Mechanick, Jeffrey I ^a   Pessah Pollack, Rachel ^a   Wyne, Kathleen ^a   Smith, Donald ^a   Brinton, Eliot A ^a   Fazio, Sergio ^a   Davidson, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PCSK9 PROTEIN, HUMAN; PROPROTEIN CONVERTASE 9;

CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; ENDOCRINOLOGIST; FEMALE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PROSPECTIVE STUDY; UNITED STATES;

CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; ENDOCRINOLOGISTS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PROPROTEIN CONVERTASE 9; PROSPECTIVE STUDIES; UNITED STATES;

EID: 85021644727     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP171764.APPGL     Document Type: Article

References (0)